Please login to the form below

Not currently logged in
Email:
Password:

metformin

This page shows the latest metformin news and features for those working in and with pharma, biotech and healthcare.

Boehringer bolsters NASH pipeline with $870m Yuhan deal

Boehringer bolsters NASH pipeline with $870m Yuhan deal

linagliptin/metformin) and Jardiance (empagliflozin).  Yuhan has retained rights to the dual agonist in its home market.

Latest news

More from news
Approximately 6 fully matching, plus 156 partially matching documents found.

Latest Intelligence

  • Market dynamics, marketing and analytics Market dynamics, marketing and analytics

    Complements are products that are often used together. Sometimes this distinction becomes blurred, as with metformin, which is a treatment for type II diabetes in its own right and also used ... market. The large product beside Januvia is metformin that,

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    sitagliptin) and Bristol-Myers Squibb (BMS), the original marketers of diabetes standard metformin under the brand name Glucophage. ... We probably have the broadest offering of products in diabetes in that middle space from when people start in

  • Pharma deals during November 2013 Pharma deals during November 2013

    The all-cash transaction is expected to close in Q1 2014. The combined company will market 22 products, including Xifaxan (rifaximin; 2012 sales of $514.5m) and Santarus' therapy Glumetza (metformin)

  • Rise of generic medicines in Portugal Rise of generic medicines in Portugal

    Generics bestsellers in volume. Simvastatin. Alprazolam. Oneprazol. Ibuprofen. Paracetamol. Metformin. Nimesulide.

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    The most commonly used oral/ non-insulin injectables are Metformin (37 per cent), Glucobay (21 per cent), Glipizide (15 per cent) and Tangshiping (11 per cent). ... In March 2013, Merck Serono and Bristol-Myers Squibb struck a deal to co-promote a

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics